Published November 9, 2026
Latest Drug Approvals from Health Canada
Weekly roundup of notable drug approvals relevant to Canada's pharmacies.
Read more about Latest Drug Approvals from Health CanadaPublished November 3, 2026
Drug Pipeline Insights: Biosimilars (2026 Q3)
2026 Q3 Update: A slowdown in biosimilar approvals, growing competition in the denosumab market despite limited product launches, and emerging biosimilar submissions representing nearly $1 billion in…
Read more about Drug Pipeline Insights: Biosimilars (2026 Q3)Published November 3, 2026
Drug Pipeline Insights: New Drugs (2026 Q3)
2026 Q3 Update: Seven new drug approvals, including two high-priority treatments, emerging therapies for rare and serious conditions, and key new drug submissions under review that could shape future…
Read more about Drug Pipeline Insights: New Drugs (2026 Q3)Published November 3, 2026
Drug Pipeline Insights: Generic Pharmaceuticals (2026 Q3)
2026 Q3 Update: New generic semaglutide approvals, ongoing availability constraints, a slowdown in generic drug approvals and submissions, and the growing role of specialty drugs in the generic pipel…
Read more about Drug Pipeline Insights: Generic Pharmaceuticals (2026 Q3)Published October 27, 2026
A Note from Our Leaders: Building Momentum for What’s Next
Neighbourhood Pharmacies releases its Q3 2026 message from our CEO and Board Chair.
Read more about A Note from Our Leaders: Building Momentum for What’s NextPublished October 7, 2026
Demystifying Specialty Pharmacy Services: A Primer Video
Neighbourhood Pharmacies’ Demystifying Specialty Pharmacy Services video looks beyond dispensing to show the work involved: patient education, clinical monitoring, reimbursement navigation, care coor…
Read more about Demystifying Specialty Pharmacy Services: A Primer Video